Mr. James Van Staveren reports

GLOW ANNOUNCES LATE FILING OF FINANCIAL STATEMENTS

Glow Lifetech Corp. is currently seeking a new auditor to perform its audit because the company's auditor has advised that it is under investigation by the professional conduct committee of the Chartered Professional Accountants of Ontario for professional misconduct. As a result of the investigation, the auditor advised the company that it is unable to continue to perform public company audits.

As a result, the company applied to the Ontario Securities Commission for a management cease trade order with respect to its audited consolidated financial statements for the year ended Dec. 31, 2023, the annual management's discussion and analysis for the same period, and management certifications of the annual filings. The OSC is of the view that there is not sufficient liquidity in the market for the company's securities, and the MCTO was denied. As a result, the company anticipates that the annual filings will not be filed by the prescribed deadline of April 29, 2024, and the company anticipates that on or about April 29, 2024, the OSC will issue a failure-to-file cease trade order against the company, which orders that general trading, whether direct or indirect, of the securities of the company cease.

Despite the CTO, a beneficial holder of a security of the company who is not, and was not as of the date of the CTO, an insider or control person of the company may sell securities of the company acquired before the date of the CTO if: (a) the sale is made through a foreign organized regulated market as defined in Section 1.1 of the Universal Market Integrity Rules of the Investment Industry Regulatory Organization of Canada; and (b) the sale is made through an investment dealer registered in a jurisdiction of Canada in accordance with applicable securities legislation. Holders of the company's securities are urged to consult with their own investment advisers or legal counsel about the implications of the CTO.

The company does not expect an interruption of the operations of the company during the CTO. Revocation of the CTO is expected to occur within a few days after the annual filings are made.

Until the company has filed the annual filings, members of the company's management and other insiders are subject to an insider trading blackout. The company confirms that, other than as disclosed in prior press releases and material change reports, there have been no material business developments since the filing of the company's latest interim financial report.

About Glow Lifetech Corp.

Glow Lifetech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption and effectiveness. Glow Lifetech has rights to the groundbreaking, plant-based MyCell Technology delivery system, which transforms poorly absorbed natural compounds into enhanced water-compatible concentrates that unlock the full healing potential of the valuable compounds.

We seek Safe Harbor.